Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial
Ingmar Wolff(Universitätsmedizin Greifswald), Matthias May(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Sebastian Hofbauer(Humboldt-Universität zu Berlin), Sabine Brookman‐May(Ludwig-Maximilians-Universität München), Dimitri Barski(Lukaskrankenhaus), Anja Rabien(Humboldt-Universität zu Berlin), Ralph M. Wirtz(Siemens Healthcare (Germany)), Flora Labonté(Humboldt-Universität zu Berlin), Andreas Gössl(Lukaskrankenhaus), Thorsten Ecke(Helios Hospital Bad Saarow), T. Otto(Lukaskrankenhaus), Anton Kravchuk(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Thorsten Schlomm(Charité - Universitätsmedizin Berlin), Dezhi Rong(Humboldt-Universität zu Berlin), Christian Gilfrich(Barmherzige Brüder Klinikum St. Elisabeth in Straubing)
Cited by 16
Related Papers
The Effect of Exercise Training Programs on Bone Mass: A Meta-analysis of Published Controlled Trials in Pre- and Postmenopausal Women
|Osteoporosis International|1999|594
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications
|Nature Biotechnology|2016|347
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
|American Journal Of Pathology|2012|323